Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36
NQ Score
0/100
N1 Content Completeness
4
Key facts
- Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36
- Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.
- Source: TWSE
- Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.
- Citation
- Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36 (Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.
- Q: What is the direct answer?
- A: Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.
- Q: What is the source and date?
- A: Source: https://openapi.twse.com.tw/financial/twse-fin-6794-2026Q1 | Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)